BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/29/2026 8:45:59 AM | Browse: 8 | Download: 5
Publication Name World Journal of Hepatology
Manuscript ID 122926
DOI 10.4254/wjh.122926
Country Thailand
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Time-dependent predictive accuracy of noninvasive liver scores for chronic kidney disease onset in metabolic dysfunction-associated steatotic liver disease
Manuscript Source Unsolicited Manuscript
All Author List Huttakan Navadurong, Padoemwut Teerawongsakul, Thananda Trakarnvanich, Witchakorn Ruamtawee, Nutachat Treerasoradaj and Supatsri Sethasine
Funding Agency and Grant Number
Corresponding Author Supatsri Sethasine, Associate Professor, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Bangkok 10300, Thailand. supatsri@nmu.ac.th
Key Words Metabolic dysfunction-associated steatotic liver disease; Chronic kidney disease; Noninvasive liver scores; Nonalcoholic fatty liver disease fibrosis score; Fibrosis-4 index; Liver stiffness measurement; Risk prediction; Time-dependent receiver operating characteristic analysis
Core Tip Nonalcoholic fatty liver disease fibrosis score (NFS) is an independent and reliable predictor of 5-year incident chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease. NFS demonstrated superior predictive accuracy compared with liver stiffness measurement and albumin-bilirubin score in this longitudinal study, with performance peaking at 3 years. Baseline NFS assessment should be incorporated into clinical practice to enable early identification of high-risk patients for nephrological intervention and individualized metabolic management.
Citation Navadurong H, Teerawongsakul P, Trakarnvanich T, Ruamtawee W, Treerasoradaj N, Sethasine S. Time-dependent predictive accuracy of noninvasive liver scores for chronic kidney disease onset in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; In press
PDF 122926-in-press.pdf
Received
2026-05-06 01:25
Peer-Review Started
2026-05-06 01:26
First Decision by Editorial Office Director
2026-05-14 02:25
Return for Revision
2026-05-14 02:25
Revised
2026-06-02 12:21
Publication Fee Transferred
2026-06-05 01:20
Second Decision by Editor
2026-06-29 02:20
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-29 08:45
Articles in Press
2026-06-29 08:45
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com